1265.8000 -17.70 (-1.38%)
NSE Dec 24, 2025 15:31 PM
Volume: 1.3M
 

1265.80
-1.38%
Deven Choksey
Dr. Reddy’s Laboratories Ltd. has entered into a definitive agreement with Janssen Pharmaceutica NV, an affiliate of Johnson & Johnson, to acquire the STUGERON® brand along with its leading local brands STUGERON® FORTE and STUGERON® PLUS.
Dr. Reddy's Laborato.. has an average target of 1281.89 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended